$ORC
Orchid Island Capital, Inc.

2020 Q4 Form 10-Q Financial Statement

#000151862120000105 Filed on October 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q1
Revenue $21.29M $27.22M $35.67M
YoY Change -48.54% -24.18% 9.98%
Cost Of Revenue $3.400M $3.300M $17.90M
YoY Change -84.19% -86.11% -11.3%
Gross Profit $17.89M $29.67M -$90.44M
YoY Change -9.96% -507.0% -885.75%
Gross Profit Margin 84.03% 108.99% -253.54%
Selling, General & Admin $1.210M $2.849M $2.141M
YoY Change 15.24% 8.24% -2.5%
% of Gross Profit 6.76% 9.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.410M $2.849M $2.141M
YoY Change 11.9% 8.24% -2.5%
Operating Profit $16.48M $26.82M -$92.58M
YoY Change -11.45% -370.32% -1094.0%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $972.0K $1.220M $417.0K
YoY Change 10.45% 45.07% -29.08%
Pretax Income $16.48M $28.08M -$91.20M
YoY Change -11.45% -431.13% -960.38%
Income Tax
% Of Pretax Income
Net Earnings $16.48M $28.08M -$91.20M
YoY Change -11.46% -431.2% -960.61%
Net Earnings / Revenue 77.4% 103.13% -255.67%
Basic Earnings Per Share $0.42 -$1.41
Diluted Earnings Per Share $0.23 $0.42 -$1.41
COMMON SHARES
Basic Shares Outstanding 69.30M shares 66.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $220.1M $199.8M $162.7M
YoY Change 13.57% 35.55% 29.23%
Cash & Equivalents $220.1M $199.8M $162.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $400.0K $0.00
Other Receivables $9.700M $10.40M
Total Short-Term Assets $230.2M $210.2M $172.8M
YoY Change 11.64% -43.69% 24.77%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.727B $3.540B $2.949B
YoY Change 3.79% -7.34% -4.52%
Other Assets $58.80M $47.50M $22.20M
YoY Change -10.77% 75.28% 226.47%
Total Long-Term Assets $3.828B $3.603B $2.990B
YoY Change 4.13% -7.15% -4.16%
TOTAL ASSETS
Total Short-Term Assets $230.2M $210.2M $172.8M
Total Long-Term Assets $3.828B $3.603B $2.990B
Total Assets $4.058B $3.813B $3.162B
YoY Change 4.53% -10.35% -2.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $600.0K $600.0K $500.0K
YoY Change 0.0% 0.0% 0.0%
Accrued Expenses $1.200M $800.0K $3.800M
YoY Change -89.19% -93.28% -25.49%
Deferred Revenue
YoY Change
Short-Term Debt $3.596B $3.281B $2.810B
YoY Change 4.28% -13.97% -1.97%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.602B $3.401B $2.823B
YoY Change 3.97% -11.24% -3.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.40M $35.40M $30.90M
YoY Change 86.18% 18.79% 423.73%
Total Long-Term Liabilities $40.40M $35.40M $30.90M
YoY Change 86.18% 18.79% 423.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.602B $3.401B $2.823B
Total Long-Term Liabilities $40.40M $35.40M $30.90M
Total Liabilities $3.643B $3.436B $2.854B
YoY Change 4.48% -11.01% -2.16%
SHAREHOLDERS EQUITY
Retained Earnings -$17.99M -$34.47M -$111.3M
YoY Change -10.58% -11.0% 229.45%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $415.3M $376.7M $308.1M
YoY Change
Total Liabilities & Shareholders Equity $4.058B $3.813B $3.162B
YoY Change 4.53% -10.35% -2.93%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q1
OPERATING ACTIVITIES
Net Income $16.48M $28.08M -$91.20M
YoY Change -11.46% -431.2% -960.61%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $24.49M $18.82M -$7.100M
YoY Change 2.99% 113.62% 346.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$309.1M -$117.6M $563.7M
YoY Change -171.27% -77.11% 208.28%
Cash From Investing Activities -$309.1M -$117.6M $563.7M
YoY Change -171.27% -77.11% 208.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$19.45M
YoY Change 255.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 336.8M 110.1M -$633.8M
YoY Change -188.38% -79.07% 285.07%
NET CHANGE
Cash From Operating Activities 24.49M 18.82M -7.100M
Cash From Investing Activities -309.1M -117.6M 563.7M
Cash From Financing Activities 336.8M 110.1M -$633.8M
Net Change In Cash 52.16M 11.32M -$633.8M
YoY Change -31.76% -46.4% -3902.19%
FREE CASH FLOW
Cash From Operating Activities $24.49M $18.82M -$7.100M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.001 pure
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
600000 USD
dei Amendment Flag
AmendmentFlag
false
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4000000 shares
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-67744000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-47964000 USD
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69295962 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63061781 shares
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001518621
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2020Q3 us-gaap Other Receivables From Broker Dealers And Clearing Organizations
OtherReceivablesFromBrokerDealersAndClearingOrganizations
0 USD
CY2019Q4 us-gaap Other Receivables From Broker Dealers And Clearing Organizations
OtherReceivablesFromBrokerDealersAndClearingOrganizations
0 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2020Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
600000 USD
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Shell Company
EntityShellCompany
false
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35236
dei Entity Registrant Name
EntityRegistrantName
Orchid Island Capital, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3269228
dei Entity Address Address Line1
EntityAddressAddressLine1
3305 Flamingo Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Vero Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32963
dei City Area Code
CityAreaCode
772
dei Local Phone Number
LocalPhoneNumber
231-1400
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
ORC
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
35013000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3882080000 USD
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
12404000 USD
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69295962 shares
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
41000 USD
CY2019Q4 us-gaap Financial Instruments Owned And Not Pledged At Fair Value
FinancialInstrumentsOwnedAndNotPledgedAtFairValue
6567000 USD
CY2020Q3 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
3540367000 USD
CY2019Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
3590921000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199805000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193770000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
47541000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
84885000 USD
CY2020Q3 us-gaap Interest Receivable
InterestReceivable
10378000 USD
CY2020Q3 us-gaap Financial Instruments Owned And Pledged As Collateral At Fair Value
FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue
3416118000 USD
CY2019Q4 us-gaap Financial Instruments Owned And Pledged As Collateral At Fair Value
FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue
3584354000 USD
CY2020Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
14239000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
0 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
603000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
100000 USD
CY2020Q3 us-gaap Assets
Assets
3812933000 USD
CY2019Q4 us-gaap Assets
Assets
3882080000 USD
CY2020Q3 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3281303000 USD
us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
63644000 USD
CY2020Q3 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
2043000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
67107000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
41151000 USD
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3448106000 USD
CY2020Q3 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
113653000 USD
CY2019Q4 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
0 USD
CY2020Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4505000 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5045000 USD
CY2020Q3 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
33295000 USD
CY2019Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
20658000 USD
CY2020Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
752000 USD
CY2020Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
590000 USD
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
622000 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
2094000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
1041000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
3486573000 USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69295962 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63061781 shares
CY2020Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
693000 USD
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
631000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
410521000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
414998000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34473000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20122000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
376741000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
395507000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3812933000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
90152000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
104795000 USD
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
27223000 USD
CY2019Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
35907000 USD
us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
23045000 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13586000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-24522000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-5135000 USD
CY2020Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
498000 USD
CY2019Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-5491000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
38440000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
39255000 USD
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1168000 USD
CY2019Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-5292000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-87630000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-61968000 USD
CY2020Q3 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
4079000 USD
CY2019Q3 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-8648000 USD
orc Net Portfolio Income
NetPortfolioIncome
-6605000 USD
orc Net Portfolio Income
NetPortfolioIncome
13303000 USD
CY2020Q3 orc Net Portfolio Income
NetPortfolioIncome
30925000 USD
CY2019Q3 orc Net Portfolio Income
NetPortfolioIncome
-5845000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
3897000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
4051000 USD
CY2020Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1252000 USD
CY2019Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1440000 USD
us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
1072000 USD
us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
1001000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
377000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
351000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
-117000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
-53000 USD
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
158000 USD
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
750000 USD
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
750000 USD
CY2020Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
242000 USD
CY2019Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
260000 USD
us-gaap Professional Fees
ProfessionalFees
841000 USD
us-gaap Professional Fees
ProfessionalFees
886000 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
240000 USD
CY2019Q3 us-gaap Professional Fees
ProfessionalFees
221000 USD
orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
852000 USD
orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
790000 USD
CY2020Q3 orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
406000 USD
CY2019Q3 orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
130000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
451000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
225000 USD
CY2019Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
57000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7650000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2849000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2632000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
28076000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-8477000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
278655000 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66014379 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54037721 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67301901 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60418985 shares
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.190
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49132000 shares
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
336079000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
10597000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11824000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8503000 USD
CY2019Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
7000 shares
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42000 USD
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-3024000 USD
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49938000 shares
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
340414000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
3533000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12859000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
28495000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
359658000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-8477000 USD
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14588000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
55324000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
48000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
391988000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
395507000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15670000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
4000 shares
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
59000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
308144000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
48772000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10935000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55000 USD
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-68000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
345968000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
28076000 USD
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12920000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15566000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2000 USD
CY2019 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
14377126 shares
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2137000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
2146000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
533000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
27000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-10349000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5447000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
16000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-32000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-57000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24383000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2898616000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3096194000 USD
orc Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
1948079000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
53000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
376741000 USD
us-gaap Profit Loss
ProfitLoss
-14351000 USD
us-gaap Profit Loss
ProfitLoss
5653000 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
167000 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
229000 USD
us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
13918000 USD
orc Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading
384314000 USD
orc Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading
389496000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
139807000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
139712000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Payments For Securities Purchased Under Agreements To Resell
ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell
30000 USD
us-gaap Proceeds From Payments For Securities Purchased Under Agreements To Resell
ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell
0 USD
orc Proceeds From Net Tba Settlements
ProceedsFromNetTbaSettlements
-1993000 USD
orc Proceeds From Net Tba Settlements
ProceedsFromNetTbaSettlements
-9846000 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
66135000 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
20032000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
109735000 USD
orc Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
27995556000 USD
orc Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
28162359000 USD
orc Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
33016040000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
40065000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
38156000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
92322000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
70000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3024000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-171925000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
840067000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-31309000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
75953000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
278655000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126263000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247346000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202216000 USD
us-gaap Interest Paid Net
InterestPaidNet
33395000 USD
us-gaap Interest Paid Net
InterestPaidNet
58197000 USD
CY2020Q3 orc Securities Acquisitions Settled In Later Period
SecuritiesAcquisitionsSettledInLaterPeriod
113653000 USD
CY2019Q3 orc Securities Acquisitions Settled In Later Period
SecuritiesAcquisitionsSettledInLaterPeriod
0 USD
CY2020Q3 orc Securities Sold Settled In Later Period
SecuritiesSoldSettledInLaterPeriod
0 USD
CY2019Q3 orc Securities Sold Settled In Later Period
SecuritiesSoldSettledInLaterPeriod
209241000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div id="TextBlockContainer10" style="position:relative;font-family:Arial;font-size:14.72px;font-stretch:condensed;color:#000000;line-height:normal;width:733px;height:153px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2911" style="position:absolute;font-weight:normal;font-style:normal;left:28.475px;top:0px;">The preparation<div style="display:inline-block;width:0.86px"> </div>of financial<div style="display:inline-block;width:1.48px"> </div>statements<div style="display:inline-block;width:1.75px"> </div>in conformity<div style="display:inline-block;width:1.33px"> </div>with GAAP<div style="display:inline-block;width:1.48px"> </div>requires management<div style="display:inline-block;width:0.34px"> </div>to make estimates<div style="display:inline-block;width:0.75px"> </div>and assumptions<div style="display:inline-block;width:0.73px"> </div>that affect </div><div id="a2913" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:19.4px;">the reported<div style="display:inline-block;width:1.3px"> </div>amounts of<div style="display:inline-block;width:1.71px"> </div>assets and<div style="display:inline-block;width:1.64px"> </div>liabilities<div style="display:inline-block;width:1.74px"> </div>and disclosure<div style="display:inline-block;width:1.04px"> </div>of contingent<div style="display:inline-block;width:1.1px"> </div>assets and<div style="display:inline-block;width:1.77px"> </div>liabilities<div style="display:inline-block;width:1.42px"> </div>at the date<div style="display:inline-block;width:1.5px"> </div>of the financial<div style="display:inline-block;width:0.86px"> </div>statements<div style="display:inline-block;width:1.75px"> </div>and </div><div id="a2915" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:38.7px;">the reported<div style="display:inline-block;width:1.3px"> </div>amounts of<div style="display:inline-block;width:1.71px"> </div>revenues and<div style="display:inline-block;width:1.41px"> </div>expenses during<div style="display:inline-block;width:1.01px"> </div>the reporting<div style="display:inline-block;width:1.02px"> </div>period. Actual<div style="display:inline-block;width:1.06px"> </div>results could<div style="display:inline-block;width:1.35px"> </div>differ from<div style="display:inline-block;width:1.71px"> </div>those estimates.<div style="display:inline-block;width:4.07px"> </div>The </div><div id="a2918" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:58.1px;">significant<div style="display:inline-block;width:1.68px"> </div>estimates<div style="display:inline-block;width:1.78px"> </div>affecting the<div style="display:inline-block;width:1.31px"> </div>accompanying<div style="display:inline-block;width:1.52px"> </div>financial<div style="display:inline-block;width:1.79px"> </div>statements<div style="display:inline-block;width:1.59px"> </div>are the fair<div style="display:inline-block;width:1.33px"> </div>values of RMBS<div style="display:inline-block;width:1.07px"> </div>and derivatives.<div style="display:inline-block;width:0.93px"> </div>Management<div style="display:inline-block;width:1.54px"> </div>believes </div><div id="a2921" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:77.4px;">the estimates<div style="display:inline-block;width:1.32px"> </div>and assumptions<div style="display:inline-block;width:0.73px"> </div>underlying<div style="display:inline-block;width:1.74px"> </div>the financial<div style="display:inline-block;width:1.33px"> </div>statements<div style="display:inline-block;width:1.59px"> </div>are reasonable<div style="display:inline-block;width:1.07px"> </div>based on the<div style="display:inline-block;width:1.39px"> </div>information<div style="display:inline-block;width:1.57px"> </div>available as<div style="display:inline-block;width:1.66px"> </div>of September<div style="display:inline-block;width:1.13px"> </div>30, </div><div id="a2924" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:96.8px;">2020;<div style="display:inline-block;width:2.43px"> </div>however,<div style="display:inline-block;width:1.94px"> </div>uncertainty<div style="display:inline-block;width:1.59px"> </div>over the ultimate<div style="display:inline-block;width:0.67px"> </div>impact that<div style="display:inline-block;width:1.59px"> </div>COVID-19<div style="display:inline-block;width:1.81px"> </div>will have on<div style="display:inline-block;width:1.41px"> </div>the global<div style="display:inline-block;width:1.73px"> </div>economy generally,<div style="display:inline-block;width:1.48px"> </div>and on Orchid’s<div style="display:inline-block;width:1.09px"> </div>business in </div><div id="a2933" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:116px;">particular, makes<div style="display:inline-block;width:1.39px"> </div>any estimates<div style="display:inline-block;width:1.2px"> </div>and assumptions<div style="display:inline-block;width:1.05px"> </div>as of September<div style="display:inline-block;width:0.77px"> </div>30, 2020 inherently<div style="display:inline-block;width:0.38px"> </div>less certain<div style="display:inline-block;width:1.34px"> </div>than they<div style="display:inline-block;width:1.85px"> </div>would be absent<div style="display:inline-block;width:0.88px"> </div>the current </div><div id="a2938" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:135.4px;">and potential<div style="display:inline-block;width:1.26px"> </div>impacts of<div style="display:inline-block;width:1.78px"> </div>COVID-19.</div></div>
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199805000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193770000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
47541000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
84885000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247346000 USD
CY2020Q3 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
3540367000 USD
CY2019Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
3590921000 USD
CY2020Q3 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
3426275000 USD
CY2020Q3 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3281303000 USD
CY2020Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0024 pure
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
3596721000 USD
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3448106000 USD
CY2019Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0203 pure
CY2020Q3 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
375000000 USD
CY2020Q3 orc Cost Basis
CostBasis
391977000 USD
CY2020Q3 orc Market Value Of Tba Contract
MarketValueOfTbaContract
391730000 USD
CY2020Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-247000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-87630000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-61968000 USD
CY2020Q3 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
4079000 USD
CY2019Q3 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-8648000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
47541000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
84885000 USD
CY2020Q3 orc Assets Pledged To Counterparties
AssetsPledgedToCounterparties
3473816000 USD
CY2019Q4 orc Assets Pledged To Counterparties
AssetsPledgedToCounterparties
3681606000 USD
CY2020Q3 orc Securities Pledged By Counterparties
SecuritiesPledgedByCounterparties
8316000 USD
CY2019Q4 orc Securities Pledged By Counterparties
SecuritiesPledgedByCounterparties
1418000 USD
CY2020Q3 orc Gross Amount Of Recognized Assets
GrossAmountOfRecognizedAssets
14239000 USD
CY2020Q3 orc Gross Amount Of Assets Offset In The Balance Sheet
GrossAmountOfAssetsOffsetInTheBalanceSheet
0 USD
CY2020Q3 orc Net Amount Of Assets Presented In The Balance Sheet
NetAmountOfAssetsPresentedInTheBalanceSheet
14239000 USD
CY2020Q3 orc Gross Amounts Of Financial Instruments Received Not Offset In Balance Sheet
GrossAmountsOfFinancialInstrumentsReceivedNotOffsetInBalanceSheet
0 USD
CY2020Q3 orc Gross Amounts Of Cash Collateral Received Not Offset In Balance Sheet
GrossAmountsOfCashCollateralReceivedNotOffsetInBalanceSheet
-1037000 USD
CY2020Q3 orc Net Amount Of Assets
NetAmountOfAssets
13202000 USD
CY2020Q3 orc Gross Amount Of Recognized Liabilties
GrossAmountOfRecognizedLiabilties
3314598000 USD
CY2020Q3 orc Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
0 USD
CY2020Q3 orc Net Amount Of Liabilities Presented In The Balance Sheet
NetAmountOfLiabilitiesPresentedInTheBalanceSheet
3314598000 USD
CY2020Q3 orc Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet
GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet
-3256536000 USD
CY2020Q3 orc Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
-46024000 USD
CY2020Q3 orc Net Amount Of Liabilities
NetAmountOfLiabilities
12038000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8477000 USD
CY2019Q4 orc Gross Amount Of Recognized Liabilties
GrossAmountOfRecognizedLiabilties
3468764000 USD
CY2019Q4 orc Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
0 USD
CY2019Q4 orc Net Amount Of Liabilities Presented In The Balance Sheet
NetAmountOfLiabilitiesPresentedInTheBalanceSheet
3468764000 USD
CY2019Q4 orc Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet
GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet
-3382255000 USD
CY2019Q4 orc Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
-83547000 USD
CY2019Q4 orc Net Amount Of Liabilities
NetAmountOfLiabilities
2962000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6244053000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35013000 USD
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
92314000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14351000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14351000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5653000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5653000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
28076000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
28076000 USD
orc Effect Of Weighting
EffectOfWeighting
-3282000 shares
orc Effect Of Weighting
EffectOfWeighting
-9078000 shares
CY2020Q3 orc Effect Of Weighting
EffectOfWeighting
-2081000 shares
CY2019Q3 orc Effect Of Weighting
EffectOfWeighting
-2639000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66014000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54038000 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67302000 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60419000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
87000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58000 shares
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8477000 USD
orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
69296000 shares
orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
63058000 shares
CY2020Q3 orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
69296000 shares
CY2019Q3 orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
63058000 shares
orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
0 shares
orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
58000 shares
CY2020Q3 orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
87000 shares
CY2019Q3 orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
0 shares

Files In Submission

Name View Source Status
0001518621-20-000105-index-headers.html Edgar Link pending
0001518621-20-000105-index.html Edgar Link pending
0001518621-20-000105.txt Edgar Link pending
0001518621-20-000105-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orc-20200930.xsd Edgar Link pending
orc-20200930_cal.xml Edgar Link unprocessable
orc-20200930_def.xml Edgar Link unprocessable
orc-20200930_lab.xml Edgar Link unprocessable
orc-20200930_pre.xml Edgar Link unprocessable
orc10q20200930.htm Edgar Link pending
orc10q20200930x311.htm Edgar Link pending
orc10q20200930x312.htm Edgar Link pending
orc10q20200930x321.htm Edgar Link pending
orc10q20200930x322.htm Edgar Link pending
orc10q20200930_htm.xml Edgar Link completed
orc2020q2p1i0.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending